Total trials
974
Active
190
Phase 3
1
Total enrollment
76,576
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Bupivacaine | — | — | — | — | — | 2 | |
| morphine | — | — | — | — | — | 2 | |
| paracetamol | — | — | — | — | — | 2 | |
| propofol | — | — | — | — | — | 1 | |
| Proprioception Exercise | — | — | — | — | — | 1 | |
| Diklofenak Sodyum | — | — | — | — | — | 1 |
Next readouts
- 2025-12-01
- 2025-12-01
- 2025-12-31
Top conditions
- Neck Pain29
- Cerebral Palsy22
- Duchenne Muscular Dystrophy18
- Low Back Pain18
- Quality of Life18
- Multiple Sclerosis17
- Stroke17
- Exercise16
Frequently asked questions about Hacettepe University
- How many clinical trials does Hacettepe University have on ClinicalTrials.gov?
- Hacettepe University is listed as the lead sponsor on 974 clinical trials in ClinicalTrials.gov, 190 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hacettepe University's trials are in Phase 3?
- 1 of Hacettepe University's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Hacettepe University focus on?
- Hacettepe University's most-studied conditions on ClinicalTrials.gov are Neck Pain, Cerebral Palsy, Duchenne Muscular Dystrophy, Low Back Pain, Quality of Life.
- When are Hacettepe University's next clinical trial readouts?
- Hacettepe University has 3 upcoming primary-completion readouts tracked here; the soonest is “A Comparative Study of Eleveld and Schnider Pharmacokinetic Models for Target-Controlled Infusion of Propofol in Sedation of Mechanically Ventilated ICU Patients”, expected around 2025-12-01.